Article
Is viral E6 oncoprotein a viable target? A critical analysis in the context of cervical cancer
2 Jun 2020
Abstract excerpt
An understanding of the pathology of cervical cancer (CC) mediated by E6/E7 oncoproteins of high-risk human papillomavirus (HPV) was developed by late 80's. But if we look at the present scenario, not a single drug could be developed to inhibit these oncoproteins and in turn, be used specifically for the treatment of CC. The readers are advised not to presume the "viability of E6 protein" as mentioned in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
